Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource
Treatment response to the first advanced treatment initiated is significantly associated with a lower long-term risk of hospitalization for IBD. Choosing the best therapy the first time may improve long-term outcomes.
Authors
- Grazziela Patrocinio Figueredo (ORCID: https://orcid.org/0000-0003-4094-7680)
- Adam J. Taylor (ORCID: https://orcid.org/0000-0001-7736-795X)
- Myrlene Sanon Aigbogun (ORCID: https://orcid.org/0000-0003-4027-1254)
- Tim Raine (ORCID: https://orcid.org/0000-0002-5855-9873)
- Gordon W. Moran (ORCID: https://orcid.org/0000-0002-8906-6908)
- Chinmay Munje (ORCID: https://orcid.org/0000-0002-0083-2128)
- Dominik Naessens
- Sudheer Kumar Vuyyuru (ORCID: https://orcid.org/0000-0002-8281-3237)
- Kun Yan (ORCID: https://orcid.org/0000-0002-6829-6130)
Institutions
- Johnson & Johnson (United States) (US)
- Nottingham University Hospitals NHS Trust (GB)
- Janssen (Belgium) (BE)
- University of Nottingham (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Global Services (Slovakia) (SK)
- Johnson & Johnson (United Kingdom) (GB)
- Janssen (United States) (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1093/ibd/izaf276
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82